002390 信邦製藥
按盤價 
4.150 +0.380 (+10.080%)
4.150 +0.380 (+10.080%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.264 | 1.495 | 4.205 | 3.342 | 4.730 |
| 總資產報酬率 ROA (%) | 1.729 | 1.110 | 3.017 | 2.310 | 2.829 |
| 投入資產回報率 ROIC (%) | 2.001 | 1.288 | 3.497 | 2.672 | 3.239 | 邊際利潤分析 |
| 銷售毛利率 (%) | 17.442 | 17.173 | 19.016 | 19.165 | 20.898 |
| 營業利潤率 (%) | 5.518 | 4.225 | 5.959 | 4.981 | 6.977 |
| 息稅前利潤/營業總收入 (%) | 5.540 | 3.350 | 6.559 | 5.549 | 7.854 |
| 淨利潤/營業總收入 (%) | 4.706 | 2.581 | 5.476 | 4.224 | 5.778 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.506 | 172.391 | 108.803 | 106.719 | 111.147 |
| 價值變動淨收益/利潤總額(%) | 0.118 | 1.578 | 2.373 | 11.942 | 0.931 |
| 營業外收支淨額/利潤總額(%) | -4.517 | -37.383 | 2.775 | -0.935 | -7.215 | 償債能力分析 |
| 流動比率 (X) | 3.575 | 2.907 | 2.629 | 2.161 | 2.024 |
| 速動比率 (X) | 2.902 | 2.320 | 2.143 | 1.777 | 1.685 |
| 資產負債率 (%) | 18.832 | 22.246 | 22.746 | 27.861 | 29.081 |
| 帶息債務/全部投入資本 (%) | 8.653 | 13.323 | 13.269 | 19.180 | 19.869 |
| 股東權益/帶息債務 (%) | 1,049.025 | 646.603 | 649.425 | 418.799 | 400.538 |
| 股東權益/負債合計 (%) | 417.123 | 334.097 | 325.857 | 249.518 | 236.408 |
| 利息保障倍數 (X) | 21.280 | 12.173 | 15.269 | 9.040 | 5.831 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 157.441 | 161.420 | 161.257 | 164.537 | 147.586 |
| 存貨周轉天數 (天) | 76.223 | 74.257 | 69.956 | 69.026 | 62.554 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 10/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
